About

Leslie Caron an expert in human pluripotent stem cell biology with 20 years of experience in disease modeling and regenerative medicine. She uses stem cell systems to identify molecular mechanisms and test drugs that affect development and diseases, with a special focus on neuromuscular disorders. Leslie received a PhD from the University of Nice-Sophia Antipolis in France and conducted her postdoctoral studies at the Harvard Stem Cell Institute where she identified a novel mouse and human cardiac stem cells. She then joined Genea, an IVF clinic based in Sydney, and was awarded a fellowship from FSHD Global Research Foundation to develop the first human pluripotent stem cells-based model for muscular dystrophy using affected human ESC lines derived from consented PGD-embryos. Leslie Join the Charles Perkins Center at the University of Sydney in 2016, where she was instrumental implementing human pluripotent stem cell technology. Recently, Leslie has developed a new stem cell therapy that appears to “cure” neuropathic pain in mice and rats, and that is currently being translated for human trials.